Regulation of alloantigen-induced cytotoxic responses by concanavalin A-activated lymphoid cells: suppression by antigen elimination. 1978

D L Kastner, and R R Rich

Spleen cells activated by concanavalin A (Con A) and subsequently irradiated with 1500 R were able to suppress the primary in vitro cytotoxic lymphocyte (CL) response of syngeneic splenocytes to H-2 disparate targets. Similarly activated and irradiated BALB/c (H-2d) splenocytes which were cultured with C57BL/6 (H-2b) stimulators for 24 hr developed cytotoxicity for H-2b, but not H-2d, tumor cell targets. This suggested that Con A-activated cells allogeneic to the stimulator might suppress the development of cytotoxic lymphocytes by eliminating antigen early in mixed leukocytes culture. This hypothesis was supported by the observation that suppression of primary cytotoxic responses was overridden by the use of greater numbers of stimulator cells. Moreover, Con A-activated (A X B)F1 lymphocytes suppressed the response of parent A to the H-2 disparate strain C to a much greater extent than they suppressed A-anti-B responses generated in such cultures. Addition of greater numbers of F1 suppressor cells did reveal a suppressive effect not readily explicable on a cytotoxic mechanism, in that modest but significant suppression of the A-anti-B response was observed. Thus, antigen elimination is a major, but not exclusive, mechanism in the suppression of CL responses by Con A-activated cells.

UI MeSH Term Description Entries
D007165 Immunosuppression Therapy Deliberate prevention or diminution of the host's immune response. It may be nonspecific as in the administration of immunosuppressive agents (drugs or radiation) or by lymphocyte depletion or may be specific as in desensitization or the simultaneous administration of antigen and immunosuppressive drugs. Antirejection Therapy,Immunosuppression,Immunosuppressive Therapy,Anti-Rejection Therapy,Therapy, Anti-Rejection,Therapy, Antirejection,Anti Rejection Therapy,Anti-Rejection Therapies,Antirejection Therapies,Immunosuppression Therapies,Immunosuppressions,Immunosuppressive Therapies,Therapies, Immunosuppression,Therapies, Immunosuppressive,Therapy, Immunosuppression,Therapy, Immunosuppressive
D007519 Isoantigens Antigens that exist in alternative (allelic) forms in a single species. When an isoantigen is encountered by species members who lack it, an immune response is induced. Typical isoantigens are the BLOOD GROUP ANTIGENS. Alloantigens,Alloantigen,Isoantigen
D008213 Lymphocyte Activation Morphologic alteration of small B LYMPHOCYTES or T LYMPHOCYTES in culture into large blast-like cells able to synthesize DNA and RNA and to divide mitotically. It is induced by INTERLEUKINS; MITOGENS such as PHYTOHEMAGGLUTININS, and by specific ANTIGENS. It may also occur in vivo as in GRAFT REJECTION. Blast Transformation,Blastogenesis,Lymphoblast Transformation,Lymphocyte Stimulation,Lymphocyte Transformation,Transformation, Blast,Transformation, Lymphoblast,Transformation, Lymphocyte,Activation, Lymphocyte,Stimulation, Lymphocyte
D008297 Male Males
D008807 Mice, Inbred BALB C An inbred strain of mouse that is widely used in IMMUNOLOGY studies and cancer research. BALB C Mice, Inbred,BALB C Mouse, Inbred,Inbred BALB C Mice,Inbred BALB C Mouse,Mice, BALB C,Mouse, BALB C,Mouse, Inbred BALB C,BALB C Mice,BALB C Mouse
D008808 Mice, Inbred CBA An inbred strain of mouse that is widely used in BIOMEDICAL RESEARCH. Mice, CBA,Mouse, CBA,Mouse, Inbred CBA,CBA Mice,CBA Mice, Inbred,CBA Mouse,CBA Mouse, Inbred,Inbred CBA Mice,Inbred CBA Mouse
D008809 Mice, Inbred C3H An inbred strain of mouse that is used as a general purpose strain in a wide variety of RESEARCH areas including CANCER; INFECTIOUS DISEASES; sensorineural, and cardiovascular biology research. Mice, C3H,Mouse, C3H,Mouse, Inbred C3H,C3H Mice,C3H Mice, Inbred,C3H Mouse,C3H Mouse, Inbred,Inbred C3H Mice,Inbred C3H Mouse
D008810 Mice, Inbred C57BL One of the first INBRED MOUSE STRAINS to be sequenced. This strain is commonly used as genetic background for transgenic mouse models. Refractory to many tumors, this strain is also preferred model for studying role of genetic variations in development of diseases. Mice, C57BL,Mouse, C57BL,Mouse, Inbred C57BL,C57BL Mice,C57BL Mice, Inbred,C57BL Mouse,C57BL Mouse, Inbred,Inbred C57BL Mice,Inbred C57BL Mouse
D008811 Mice, Inbred DBA An inbred strain of mouse. Specific substrains are used in a variety of areas of BIOMEDICAL RESEARCH such as DBA/1J, which is used as a model for RHEUMATOID ARTHRITIS. Mice, DBA,Mouse, DBA,Mouse, Inbred DBA,DBA Mice,DBA Mice, Inbred,DBA Mouse,DBA Mouse, Inbred,Inbred DBA Mice,Inbred DBA Mouse
D003208 Concanavalin A A MANNOSE/GLUCOSE binding lectin isolated from the jack bean (Canavalia ensiformis). It is a potent mitogen used to stimulate cell proliferation in lymphocytes, primarily T-lymphocyte, cultures.

Related Publications

D L Kastner, and R R Rich
July 1977, Journal of immunology (Baltimore, Md. : 1950),
D L Kastner, and R R Rich
September 1978, Journal of immunology (Baltimore, Md. : 1950),
D L Kastner, and R R Rich
January 1973, International archives of allergy and applied immunology,
D L Kastner, and R R Rich
September 1979, Journal of immunology (Baltimore, Md. : 1950),
D L Kastner, and R R Rich
January 1979, Cellular immunology,
D L Kastner, and R R Rich
April 1979, Journal of immunology (Baltimore, Md. : 1950),
D L Kastner, and R R Rich
September 1985, Pediatric research,
Copied contents to your clipboard!